BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11805178)

  • 21. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
    Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
    Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.
    Oh EJ; Ryu HM; Choi SY; Yook JM; Kim CD; Park SH; Chung HY; Kim IS; Yu MA; Kang DH; Kim YL
    Am J Nephrol; 2010; 31(1):58-67. PubMed ID: 19887789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
    Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
    Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.
    Choi HY; Kim DK; Lee TH; Moon SJ; Han SH; Lee JE; Kim BS; Park HC; Choi KH; Ha SK; Han DS; Lee HY
    Perit Dial Int; 2008; 28(2):174-82. PubMed ID: 18332454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture.
    Simonsen O; Sterner G; Carlsson O; Wieslander A; Rippe B
    Perit Dial Int; 2006; 26(3):353-9. PubMed ID: 16722029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.
    Zareie M; Hekking LH; Welten AG; Driesprong BA; Schadee-Eestermans IL; Faict D; Leyssens A; Schalkwijk CG; Beelen RH; ter Wee PM; van den Born J
    Nephrol Dial Transplant; 2003 Dec; 18(12):2629-37. PubMed ID: 14605288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
    Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
    Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
    Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
    Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
    Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
    Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
    Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalized dilation of the visceral microvasculature by peritoneal dialysis solutions.
    Zakaria el R; Spain DA; Harris PD; Garrison RN
    Perit Dial Int; 2002; 22(5):593-601. PubMed ID: 12455570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
    Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F
    J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effects of amino-acid-based versus glucose-based continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Schenk U; Kiefer T; Hübel E; Weber J; Mettang T; Passlick-Deetjen J; Kuhlmann U
    Nephron; 1994; 68(3):338-46. PubMed ID: 7838257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
    Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
    Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
    Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se.
    Witowski J; Bender TO; Wisniewska-Elnur J; Ksiazek K; Passlick-Deetjen J; Breborowicz A; Jörres A
    Perit Dial Int; 2003; 23(4):381-90. PubMed ID: 12968847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.